Advanced Cell Diagnostics
Acquired- Headquarters
- Newark, California
- Employees
- 51–200
- Business Model
- B2B
- Website
- acdbio.com
- Last Round
- Series CJan 2015
- Rounds
- 1
About
Biotech company providing RNA in-situ hybridization technology (RNAscope) for single-molecule RNA detection; acquired by Bio-Techne.
Summary
Advanced Cell Diagnostics is a Biotech company based in Newark, United States. Its most recent funding was a Series C round in Jan 2015. Investors include Bio-Techne Corporation and Summit Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2016
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...